Abstract
Positron-emission tomography (PET) is a quantitative technique that produces images of biological or physiological processes. The nature of the image depends on the tracer used: common tracers used to study HE include 18F-fluordeoxyglucose, a marker of glucose metabolism; 15O-water, a marker of cerebral blood flow; and 13N-ammonia, a marker of ammonia metabolism. Combined blood flow and ammonia metabolism studies can be used to calculate the permeability surface area product for ammonia at the blood brain barrier. To take full advantage of PET, the data should be analyzed using one of the several sophisticated image processing and analysis techniques that are available. Thus, PET is an ideal technique to evaluate ammonia metabolism and, because of a close linkage of blood flow and glucose metabolism with neural activity, to investigate the neural response to drugs and other treatments and to examine neural systems that mediate specific tasks that are impaired in patients with HE.
Similar content being viewed by others
REFERENCES
Cooper, A.J., McDonald, J.M., Gelbard, A.S., Gledhill, R.F. and Duffy, T.E. (1979). The metabolic fate of 13N-labeled ammonia in rat brain. J. Biol. Chem. 254:4982–4992.
Ehrlich, M., Plum, F. and Duffy, T.E. (1980). Blood and brain ammonia concentrations after portacaval anastomosis. Effects of acute ammonia loading. J. Neurochem. 34:1538–1542.
Frackowiak, R.S.J., Friston, K.J., Frith, C.D., Dolan, R.J. and Mazziotta, J.C. (1997). Human Brain Function. New York: Academic Press.
Lockwood, A.H., Finn, R.D., Campbell, J.A. and Richman, T.B. (1980). Factors that affect the uptake of ammonia by the brain: the blood-brain pH gradient. Brain Res. 181: 259–266.
Lockwood, A.H., McDonald, J.M., Reiman, R.E., Gelbard, A.S., Laughlin, J.S., Duffy, T.E. and Plum, F. (1979). The dynamics of ammonia metabolism in man. Effects of liver disease and hyperammonemia. J. Clin. Invest. 63:449–460.
Lockwood, A.H., Murphy, B.W., Donnelly, K.Z., Mahl, T.C. and Perini, S. (1993). Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 18:1061–1068.
Lockwood, A.H., Weissenborn, K., Burchert, W., Bokemeyer, M. and Wack, D.S. (1998). Neuropsychological test deficits correlate with altered cerebral glucose metabolism in patients with non-alcoholic cirrhosis. Neurology 50:A253 (Abstract)
Lockwood, A.H., Yap, E.W.H., Rhoades, H.M. and Wong, W.-H. (1991a). Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J. Cereb. Blood Flow Metab. 11:331–336.
Lockwood, A.H., Yap, E.W.H. and Wong, W.-H. (1991b). Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J. Cereb. Blood Flow Metab. 11:337–341.
Pomier Layrargues, G., Giguere, J.F., Lavoie, J., Willems, B. and Butterworth, R.F. (1989). Pharmacokinetics of benzodiazepine antagonist Ro 15-1788 in cirrhotic patients with moderate or severe liver dysfunction. Hepatology 10:969–972.
Posner, M.I. and Petersen, S.E. (1990). The attention system of the human brain. Annu. Rev. Neurosci. 13:25–42.
Samson, Y., Bernuau, J., Pappata, S., Chavoix, C., Baron, J.C. and Maziere, M.A. (1987). Cerebral uptake of benzodiazepine measured by positron emission tomography in hepatic encephalopathy letter. N. Engl. J. Med. 316:414–415.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lockwood, A.H. Positron Emission Tomography in the Study of Hepatic Encephalopathy. Metab Brain Dis 13, 303–309 (1998). https://doi.org/10.1023/A:1020684724992
Issue Date:
DOI: https://doi.org/10.1023/A:1020684724992